Lidocaine (topical) vs Bendamustine

Interacting Drugs
Lidocaine (topical)
vs
Bendamustine
Security Level
Minor, Monitor Therapy
Mechanism
Bendamustine: CYP1A2 Inhibitors (Strong) may increase the serum concentration of Bendamustine. Concentrations of the active metabolites of bendamustine may be decreased.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Lidocaine (topical) vs Bendamustine